Kodiak Sciences Inc. (KOD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Kodiak Sciences Inc. (KOD) closed at USD 81.09 on 2026-10-14, a change of +321.2 % over the past year, with a market capitalization of USD 5.54B.

Kodiak Sciences Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Kodiak Sciences Inc. key figures

Previous close

USD 81.09 (2026-10-14)

1-year change

+321.2 %

Market cap

USD 5.54B

Enterprise value

USD 5.45B

P/E ratio (trailing)

-21.03

P/E ratio (forward)

-25.65

EPS (trailing)

-4.19

EPS (forward)

-3.44

PEG ratio

n/a

Price to book

90.47

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.12

Employees

141

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Kodiak Sciences Inc. and compare it with other stocks.